Provided by Tiger Trade Technology Pte. Ltd.

BEONE MEDICINES

212.200
-3.200-1.49%
Volume:884.40K
Turnover:189.13M
Market Cap:327.21B
PE:142.48
High:216.400
Open:215.400
Low:212.000
Close:215.400
52wk High:235.600
52wk Low:153.000
Shares:1.54B
HK Float Shares:1.43B
Volume Ratio:0.97
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.489
ROE:14.66%
ROA:7.46%
PB:8.07
PE(LYR):142.48
PS:6.81

Loading ...

Stock Track | BEIGENE Soars 5.11% Intraday on Stellar Q1 Earnings with 178-Fold Net Profit Surge

Stock Track
·
May 07

BEIGENE Shares Surge Over 4% Post-Earnings on Stellar Q1 Performance

Stock News
·
May 07

Lithium Carbonate Spot Prices Surge Significantly; BEIGENE Reports 178-Fold Jump in Q1 Net Profit

Stock News
·
May 07

BeOne Registers 398.88 Million Shares for Potential Resale via New Form S-3

Bulletin Express
·
May 07

BEIGENE Reports Q1 2026 Net Profit of 1.608 Billion Yuan

Stock News
·
May 06

BeiGene Q1 Adj. EPS $3.24 Beats $0.79 Estimate, Sales $1.513B Beat $1.441B Estimate.

Benzinga Earnings
·
May 06

Earning Preview: BEIGENE Q1 revenue is expected to increase, and institutional views lean positive

Earnings Agent
·
Apr 29

BeOne Medicines posts 2026 AGM proxy materials online; shareholders to vote on 20 proposals including financials, board re-elections and 20% share issue mandate

Bulletin Express
·
Apr 28

BEIGENE logs first GAAP profit on 40% revenue surge; BRUKINSA sales hit USD 3.90 billion

Bulletin Express
·
Apr 28

BeOne Medicines Announces June 11, 2026 AGM; Shareholders to Vote on 20 Proposals Including Financial Statements, Board Elections and Share Mandates

Bulletin Express
·
Apr 28

Beigene Announces 20-Proposal Slate for 11 June 2026 AGM; Seeks Fresh Share Issue, Buy-Back Mandates and Board Re-elections

Bulletin Express
·
Apr 28

BeOne Medicines Sets 22 May 2026 Record Date for Annual General Meeting Attendance

Bulletin Express
·
Apr 28

Market Essentials: Key Factors Influencing Stock Market Trends on April 28, 2026

Deep News
·
Apr 28

Stock Market Guide: Announcements and Trading Alerts for Shanghai and Shenzhen Exchanges on April 28, 2026

Deep News
·
Apr 28

BEIGENE Secures Global Exclusive Rights to Develop Trispecific Therapy Through Huahui Anjian Partnership

Stock News
·
Apr 27

BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review

Bulletin Express
·
Apr 22

China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development

Stock News
·
Apr 16

Beigene Reports Profit Turnaround with 2025 Net Income of 1.461 Billion Yuan

Stock News
·
Apr 14

百济神州2025年营收大幅增长并实现首度年度盈利

Bulletin Express
·
Apr 14

BeiGene posts 2025 Responsible Business & Sustainability Report: FY25 revenue hits $5.30 billion, Scope 1 & 2 emission intensity down 25%

Bulletin Express
·
Apr 14